Special Production Exemplary Solidarity from Pharmactive

Pharmactive will specially produce hand antiseptics and offer 55 thousand pieces of one liter and 100 thousand bottles of 60 ml hand antiseptics to healthcare professionals as unconditional support. The company has also sent 1,500 "Emergency Needs Packages" containing sanitarian protective goggles, masks, gloves, hand antiseptics and protective gowns to the healthcare professionals across Turkey.

BULLETIN DOWNLOAD >

WORLD-LEADING INNOVATION IN MEDICINE HAS MADE ITS FIRST INVESTMENT IN TURKEY

Gilead Sciences, which is placed on the top of pharmaceutical industry 2019 innovation index in the world as multinational science company, will produce the most innovative and life-saving medicines in Turkey, in line with the strategic local production priorities of the state. After Canada and Ireland, Turkey will be the third production base of Gilead Sciences which is currently manufacturing for related medicines. Gilead Sciences Turkey which signs an agreement with Pharmactive İlaç for local production, will produce more than %70 of the total endorsement in Turkey.

BULLETIN DOWNLOAD >

PHARMACTIVE COLLABORATION IS GROWING WITH CHIESI

Chiesi and Pharmactive are expanding their co-marketing strategy and production collaboration in 2018. Italy-based international pharmaceutical company Chiesi Turkey which has been operating more than 10 years in Turkey, as part of the strategies to improve local investment, signed a local production agreement with Pharmactive for nasal steroid medicine with beclomethazone active ingredient. Umut Meriç, General Manager of Chiesi Turkey and Haluk Sancak, Board Chairman of Pharmactive and with the both company’s management team have attended to the signing ceremony of Pharmactive İlaç which is held at the production facility in Çerkezköy.
BULLETIN DOWNLOAD >

CHIESI İLE PHARMACTIVE İŞBİRLİĞİ BÜYÜYOR

Chiesi ile Pharmactive, 2018 yılında başlattıkları ortak pazarlama stratejisi ve üretim işbirliğini genişletiyor. Türkiye’de 10 yılı aşkın bir süredir faaliyet gösteren İtalya merkezli uluslararası ilaç firması Chiesi Türkiye, yerel yatırımlarını artırmaya yönelik stratejisi kapsamında, Pharmactive ile beklometazon etken maddeli nazal steroid ilacı için yerel üretim anlaşması imzaladı. Pharmactive İlaç'ın Çerkezköy'deki üretim tesisinde gerçekleşen imza törenine her iki firmanın yönetim ekipleriyle birlikte Chiesi Türkiye Genel Müdürü Umut Meriç ve Pharmactive Yönetim Kurulu Başkanı Haluk Sancak katıldı.

BULLETIN DOWNLOAD >

İLAÇTA DÜNYA İNOVASYON LİDERİ TÜRKİYE’DE İLK YATIRIMINI YAPTI

İlaç sektörü 2019 inovasyon endeksinde dünyada ilk sırada1 yer alan çok uluslu bilim şirketi Gilead Sciences, devletin stratejik yerli üretim öncelikleri doğrultusunda en yenilikçi ve hayat kurtaran ilaçlarını Türkiye’de üretecek. Türkiye, Gilead Sciences’ın ilgili ilaçlar için halihazırda üretim yapmakta olduğu Kanada ve İrlanda’dan sonra üçüncü üretim üssü olacak. Yerli üretim için Pharmactive İlaç ile iş birliği anlaşması imzalayan Gilead Sciences Türkiye, böylece toplam cirosunun %70’inden fazlasını Türkiye’de üretir duruma gelecek. 

BULLETIN DOWNLOAD >

PHARMACTIVE IN ALBANIA

Pharmactive, one of Turkey's leading companies in the pharmaceutical industry, launches its representative office in Albania. Pharmactive exports products to 35 countries, particularly the EU countries, in an effort to build healthier societies. Pharmactive will offer 19 products within 13 treatment areas in Albania. 

BULLETIN DOWNLOAD >

PHARMACTIVE JOINED FORCES WITH CHIESI

The Italy-based international pharmaceutical company Chiesi has been operating in Turkey for over 10 years and now extends its products range within the primary care group. The firm also decided to locally manufacture the major products within their primary care and special care portfolio. In the first phase of this collaboration, a nasal steroid spray will be produced on a contractual basis. The firm's near future plans also include manufacturing other products within their portfolio in Turkey.

BULLETIN DOWNLOAD >

BIOTECHNOLOGICAL BROTHERHOOD

Pharmactive became the first Turkish company with completely domestic capital to start an investment partnership with Polus that stands out for its innovative products in South Korea - the country using the most advanced technology in the world in developing and producing biological drugs from stem cells. The two companies have agreed to build a production facility in Turkey. 

BULLETIN DOWNLOAD >

PHARMACTIVE IN EUROPE

One of the leading pharmaceutical companies of our country, Pharmactive, with 100% domestic capital, has just begun to export to European countries after the Middle East, Balkans and Asian countries.

BULLETIN DOWNLOAD >

MEANINGFUL VISIT FROM PHARMACTIVE

The Pharmactive Medicine Volunteer Team met with children who were treated at the Okmeydanı Reserch and Training Hospital. Into kids, holiday gifts were given where came from all over Turkey.The Pharmactive Medicine was established within Saya Group within the understanding of "How happy is one who can be a remedy to a misery" has added a new one to corporate social responsibility projects. 

BULLETIN DOWNLOAD >

MASTER OF MASTERS WAS AT CERMODERN

The most comprehensive Bedri Rahmi Eyüboğlu Retrospective Exhibition prepared in Turkey until now has met with Ankara art lovers at Cermodern under Pharmactive sponsorship. Large number of masterpieces that belong to master presented first time to the tastes of art lovers at exhibition; “Sevmek Güzel Meslek” was given as name from his line of a poetry of painter, poet and writer Bedri Rahmi Eyüboğlu who produced works in different disciplines of art.

BULLETIN DOWNLOAD >

OUR RENEWED EU GMP CERTIFICATE

Pharmactive successfully completed the  German Ministry of Health authority audit for the 2nd time. Pharmactive, which received full marks at audit on April, had became deserved to renew the EU GMP which meant the European Union Good Manufacturing Practice  certification for its solid and liquid production lines.